Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 75, Topic 2
In Progress

Diagnostic Assessment and Classification of Sedation and Agitation in the ICU

Lesson Progress
0% Complete
Diagnostic Assessment and Classification of Sedation and Agitation in the ICU

Diagnostic Assessment and Classification of Sedation and Agitation in the ICU

Objective Icon A checkmark inside a circle, symbolizing an achieved goal.

Objective

Apply diagnostic criteria and classification systems to evaluate sedation depth and agitation severity, guiding personalized ICU management.

1. Clinical Manifestations and Initial Diagnostic Assessment

Distinguish agitation from oversedation by combining behavioral observations with physiologic data to identify underlying causes and prevent complications.

A. Presentation of Agitation

  • Behavioral cues: Restlessness, combativeness, attempts to remove tubes or catheters.
  • Hemodynamic signs: Tachycardia, hypertension, diaphoresis, mydriasis.
  • Ventilator asynchrony: High peak pressures, “bucking” the ventilator, frequent alarm triggers.

B. Presentation of Oversedation

  • Respiratory: Hypoventilation, shallow breathing, rising PaCO₂ on arterial blood gas.
  • Neurologic: Minimal or no response to voice or physical stimulation (RASS –4 to –5).
  • Airway risk: Loss of protective cough and gag reflexes, increasing aspiration potential.

C. Differential Diagnoses

  • Inadequate analgesia or uncontrolled pain
  • Delirium (hyperactive, hypoactive, or mixed)
  • Withdrawal syndromes (alcohol, benzodiazepines, opioids)
  • Acute neurologic events (intracranial hemorrhage, ischemic stroke)
  • Metabolic encephalopathies (electrolyte disturbances, hepatic/renal failure)
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl Expand/Collapse Icon

Hemodynamic surges often precede overt agitation—monitor trends in heart rate and blood pressure to intervene early.

2. Diagnostic Modalities

Laboratory, imaging, and neurophysiologic tools help confirm etiology and tailor sedation strategies.

A. Essential Laboratory Tests

  • Electrolytes: Na, K, Ca, Mg (detect osmolar shifts, seizure risk)
  • Glucose: Hypo- or hyperglycemia can mimic agitation or lethargy
  • Renal/hepatic panels: Guide drug clearance and detect encephalopathy
  • Inflammatory markers: WBC count, CRP, procalcitonin for sepsis-related delirium
  • Arterial blood gas: Assess ventilation (PaO₂, PaCO₂) and acid–base status
  • Lactate: Evaluates tissue perfusion and shock states

B. Imaging Studies

  • Head CT: Rapid exclusion of hemorrhage, mass effect, hydrocephalus.
  • Brain MRI: Sensitive for ischemia, demyelination, posterior reversible encephalopathy.
  • Point-of-care ultrasound (POCUS): Optic nerve sheath diameter as a surrogate for intracranial pressure. (Editor’s Note: limited ICU validation—sensitivity/specificity data needed)

C. Neurophysiologic Monitoring

  • Continuous EEG: Gold standard for nonconvulsive seizure detection and burst suppression titration.
  • Bispectral index (BIS): Processed EEG index (0–100) correlating with sedation depth under paralysis. Limitations include EMG artifacts, ketamine effects, and limited validation in non-paralyzed patients.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl Expand/Collapse Icon

Correct chronic hyponatremia at no more than 8–10 mEq/L per 24 hours to avoid osmotic demyelination.

3. Classification Systems and Severity Scoring

Apply validated scales to quantify arousal and delirium, then integrate general severity scores for prognostication.

A. Sedation Scales

  • Richmond Agitation-Sedation Scale (RASS): +4 (combative) to –5 (unarousable). Target for light sedation: RASS –2 to 0.
  • Sedation-Agitation Scale (SAS): 1 (unarousable) to 7 (dangerous agitation).

B. Agitation-Specific Tool

  • Motor Activity Assessment Scale (MAAS): 0 (no response) to 6 (dangerous agitation).

C. Delirium Screening

  • Confusion Assessment Method for the ICU (CAM-ICU): Assesses acute change, inattention, disorganized thinking, and altered consciousness; valid if RASS ≥ –3.
  • Intensive Care Delirium Screening Checklist (ICDSC): An eight-domain checklist where a score ≥4 indicates delirium.

D. General Severity Scores

  • APACHE II/IV and SOFA: Quantify organ dysfunction and mortality risk; correlate with delirium incidence but are not designed for sedation titration.
Comparison of ICU Sedation, Agitation, and Delirium Scales
Scale Domain Range Primary Use
RASS Arousal/Behavior +4 to –5 Sedation titration, extubation readiness
SAS Sedation/Agitation 1 to 7 Equivalent to RASS
MAAS Motor Activity 0 to 6 Detailed high-agitation grading
CAM-ICU Delirium Screening Positive / Negative Detect presence of delirium
ICDSC Delirium Screening 0 to 8 Assess delirium severity
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl Expand/Collapse Icon

Embedding these scales in the electronic health record enhances compliance and allows for real-time risk stratification and automated alerts.

4. Diagnostic Workflow and Decision Algorithms

A structured, stepwise approach streamlines the evaluation of abnormal arousal and triggers advanced diagnostics appropriately.

ICU Agitation/Sedation Diagnostic Workflow A flowchart showing the decision-making process for managing a patient with altered arousal in the ICU. It starts with assessing the RASS score, then branches to different pathways for agitation (RASS > +1), oversedation (RASS < -3), and refractory agitation. 1. Assess RASS Score 2. RASS > +1 (Agitated) Evaluate Pain, Delirium, & Withdrawal (PAWD) Administer analgesics 3. RASS < –3 (Oversedated) Review sedative infusions Check for accumulation Check metabolic labs If no improvement 4. Refractory Agitation (RASS > +2) Obtain continuous EEG Obtain Head CT Consult Neurology/Neurocritical Care
Figure 1: Diagnostic Algorithm for Altered Arousal in the ICU. This stepwise approach prioritizes the assessment of reversible causes (pain, withdrawal) before escalating to advanced neurodiagnostics for refractory agitation.

Case Vignette

A 68-year-old ventilated patient on a propofol infusion scores RASS +3 (very agitated). Initial labs reveal a serum sodium of 120 mEq/L. After gradual correction of the hyponatremia and administration of a low-dose haloperidol, the patient’s RASS score improves to 0 (alert and calm) within 8 hours, highlighting the importance of addressing metabolic causes.

Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl Expand/Collapse Icon

Use threshold RASS, CAM-ICU, and APACHE/SOFA triggers to launch early mobility and delirium‐prevention bundles (e.g., the ABCDEF bundle).

5. Practice Nuances and Pitfalls

Recognize tool limitations and avoid overreliance on single data points; maintain thorough documentation for continuity of care.

Common Pitfalls

  • Misinterpreting mild lab abnormalities without clinical correlation.
  • Overreliance on BIS monitoring during ketamine administration or in the presence of EMG interference.
  • Applying delirium screening tools (CAM-ICU, ICDSC) to patients who are deeply sedated (RASS ≤ –4), as the results are invalid.
  • Ordering unnecessary imaging in low-risk, clinically stable patients without a clear indication.

Documentation Best Practices

  • Chart RASS and CAM-ICU or ICDSC scores at regular intervals (e.g., every 4 hours).
  • Note differential diagnoses and the clinical rationale for any sedation adjustments.
  • Use structured EHR templates to ensure accurate and complete handoffs between care teams.

Key Points

  • Early separation of pain, agitation, and delirium is crucial to prevent overtreatment and guide appropriate therapy.
  • Light sedation targets (RASS –2 to 0) are associated with reduced mechanical ventilation time and lower incidence of delirium.
  • Combine clinical scales with objective monitors (e.g., EEG) when indicated, particularly in paralyzed or refractory patients.
  • Meticulous documentation of assessments and interventions ensures team alignment and safer transitions of care.

References

  1. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult ICU patients. Crit Care Med. 2013;41(1):263–306.
  2. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult ICU patients. Crit Care Med. 2018;46(9):e825–e873.
  3. Ely EW, Shintani A, Truman B, et al. Reliability and validity of the Richmond Agitation-Sedation Scale in ICU patients. JAMA. 2003;289(22):2983–2991.
  4. Ely EW, Inouye SK, Bernard GR, et al. Validity and reliability of the CAM-ICU in mechanically ventilated patients. JAMA. 2001;286(21):2703–2710.
  5. Fraser GL, Riker RR. Bispectral index monitoring in the ICU provides more signal than noise. Pharmacotherapy. 2005;25(1 Suppl):19S–27S.
  6. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol (ABC trial). Lancet. 2008;371(9607):126–134.